Janus Henderson Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,398,640
Closed -$368M 1703
2021
Q1
$368M Sell
2,398,640
-3,271
-0.1% -$444K 0.17% 141
2020
Q4
$301M Buy
2,401,911
+9,724
+0.4% +$1.09M 0.14% 162
2020
Q3
$243M Buy
2,392,187
+409,959
+21% +$41.8M 0.13% 171
2020
Q2
$193M Buy
1,982,228
+22,452
+1% +$2.09M 0.11% 198
2020
Q1
$163M Sell
1,959,776
-1,121
-0.1% -$109K 0.11% 201
2019
Q4
$218M Buy
1,960,897
+200,498
+11% +$20.6M 0.11% 206
2019
Q3
$175M Buy
1,760,399
+1,723,170
+4,629% +$171M 0.09% 227
2019
Q2
$3.69M Sell
37,229
-52,824
-59% -$5.04M ﹤0.01% 1086
2019
Q1
$9.93M Buy
90,053
+10,994
+14% +$1.15M 0.01% 920
2018
Q4
$7.27M Buy
79,059
+15,642
+25% +$1.58M ﹤0.01% 928
2018
Q3
$6.99M Buy
63,417
+57,609
+992% +$6M ﹤0.01% 979
2018
Q2
$542K Buy
5,808
+1,450
+33% +$125K ﹤0.01% 1281
2018
Q1
$362K Buy
+4,358
New +$387K ﹤0.01% 1297

Other funds holding PRAH

Janus Henderson Group's PRAH Position: Q2 2021 in Review

Janus Henderson Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 2,398,640 shares — an estimated $368M sold.

Janus Henderson Group first reported a position in PRAH in Q1 2018 and held it in 13 quarters. The position peaked at $368M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Janus Henderson Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Janus Henderson Group sold 2,398,640 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $368M.
  • Janus Henderson Group first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 13 quarters.
  • Janus Henderson Group's PRA Health Sciences, Inc. position peaked at $368M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.